ID   FOXM1_RAT               Reviewed;         759 AA.
AC   P97691;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 2.
DT   24-JAN-2024, entry version 171.
DE   RecName: Full=Forkhead box protein M1;
DE   AltName: Full=INS-1 winged helix;
DE   AltName: Full=Winged-helix factor from INS-1 cells;
GN   Name=Foxm1; Synonyms=Win;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4).
RC   TISSUE=Insulinoma;
RX   PubMed=9242644; DOI=10.1074/jbc.272.32.19827;
RA   Yao K.-M., Sha M., Lu Z., Wong G.G.;
RT   "Molecular analysis of a novel winged helix protein, WIN. Expression
RT   pattern, DNA binding property, and alternative splicing within the DNA
RT   binding domain.";
RL   J. Biol. Chem. 272:19827-19836(1997).
CC   -!- FUNCTION: Transcription factor regulating the expression of cell cycle
CC       genes essential for DNA replication and mitosis. Plays a role in the
CC       control of cell proliferation. Also plays a role in DNA break repair,
CC       participating in the DNA damage checkpoint response. Promotes
CC       transcription of PHB2. {ECO:0000250|UniProtKB:Q08050}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00089}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P97691-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P97691-2; Sequence=VSP_001550;
CC       Name=3;
CC         IsoId=P97691-3; Sequence=VSP_001549;
CC       Name=4;
CC         IsoId=P97691-4; Sequence=Not described;
CC   -!- TISSUE SPECIFICITY: Highly expressed in thymus and testis, but weakly
CC       in intestine and lung. Appears to be expressed only in adult organs
CC       containing proliferating/cycling cells or in response to growth
CC       factors.
CC   -!- DEVELOPMENTAL STAGE: Expressed from 12 dpc to neonate in developing
CC       pancreas. Also expressed at 14 dpc in liver, thymus, testis and fat
CC       (pregnant mother).
CC   -!- INDUCTION: Activated in S phase.
CC   -!- PTM: Phosphorylated in M (mitotic) phase. Phosphorylation by the
CC       checkpoint kinase CHEK2 in response to DNA damage increases the FOXM1
CC       protein stability probably stimulating the transcription of genes
CC       involved in DNA repair. Phosphorylated by CDK1 in late S and G2 phases,
CC       creating docking sites for the POLO box domains of PLK1. Subsequently,
CC       PLK1 binds and phosphorylates FOXM1, leading to activation of
CC       transcriptional activity and subsequent enhanced expression of key
CC       mitotic regulators (By similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: [Isoform 4]: Has been shown to exist only in human so
CC       far. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U83112; AAC63594.1; -; mRNA.
DR   AlphaFoldDB; P97691; -.
DR   SMR; P97691; -.
DR   STRING; 10116.ENSRNOP00000008003; -.
DR   PhosphoSitePlus; P97691; -.
DR   PaxDb; 10116-ENSRNOP00000008003; -.
DR   UCSC; RGD:61807; rat. [P97691-1]
DR   AGR; RGD:61807; -.
DR   RGD; 61807; Foxm1.
DR   eggNOG; KOG2294; Eukaryota.
DR   InParanoid; P97691; -.
DR   Reactome; R-RNO-156711; Polo-like kinase mediated events.
DR   Reactome; R-RNO-69273; Cyclin A/B1/B2 associated events during G2/M transition.
DR   PRO; PR:P97691; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; ISO:RGD.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0001889; P:liver development; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0032873; P:negative regulation of stress-activated MAPK cascade; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:2000781; P:positive regulation of double-strand break repair; ISO:RGD.
DR   GO; GO:2000648; P:positive regulation of stem cell proliferation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0051726; P:regulation of cell cycle; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0046578; P:regulation of Ras protein signal transduction; ISO:RGD.
DR   GO; GO:2000377; P:regulation of reactive oxygen species metabolic process; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0051591; P:response to cAMP; IEP:RGD.
DR   GO; GO:0034698; P:response to gonadotropin; IEP:RGD.
DR   GO; GO:0072089; P:stem cell proliferation; ISO:RGD.
DR   GO; GO:0001570; P:vasculogenesis; ISO:RGD.
DR   CDD; cd20029; FH_FOXM; 1.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   InterPro; IPR047516; FH_FOXM1.
DR   InterPro; IPR001766; Fork_head_dom.
DR   InterPro; IPR042839; FOXM1.
DR   InterPro; IPR018122; TF_fork_head_CS_1.
DR   InterPro; IPR030456; TF_fork_head_CS_2.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR46878; FORKHEAD BOX PROTEIN M1; 1.
DR   PANTHER; PTHR46878:SF1; FORKHEAD BOX PROTEIN M1; 1.
DR   Pfam; PF00250; Forkhead; 1.
DR   PRINTS; PR00053; FORKHEAD.
DR   SMART; SM00339; FH; 1.
DR   SUPFAM; SSF46785; Winged helix' DNA-binding domain; 1.
DR   PROSITE; PS00657; FORK_HEAD_1; 1.
DR   PROSITE; PS00658; FORK_HEAD_2; 1.
DR   PROSITE; PS50039; FORK_HEAD_3; 1.
PE   2: Evidence at transcript level;
KW   Activator; Alternative splicing; Cell cycle; DNA damage; DNA repair;
KW   DNA-binding; Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN           1..759
FT                   /note="Forkhead box protein M1"
FT                   /id="PRO_0000091865"
FT   DNA_BIND        234..326
FT                   /note="Fork-head"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00089"
FT   REGION          1..54
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          94..165
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          328..349
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          530..556
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          572..643
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          681..706
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        37..54
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        94..136
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        530..552
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        601..617
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         330
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08050"
FT   MOD_RES         375
FT                   /note="Phosphoserine; by CHEK2"
FT                   /evidence="ECO:0000250|UniProtKB:Q08050"
FT   MOD_RES         521
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08050"
FT   MOD_RES         608
FT                   /note="Phosphothreonine; by CDK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q08050"
FT   MOD_RES         624
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08050"
FT   MOD_RES         726
FT                   /note="Phosphoserine; by PLK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q08050"
FT   MOD_RES         735
FT                   /note="Phosphoserine; by PLK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q08050"
FT   CROSSLNK        200
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q08050"
FT   CROSSLNK        324
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q08050"
FT   CROSSLNK        355
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q08050"
FT   CROSSLNK        421
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q08050"
FT   CROSSLNK        439
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q08050"
FT   VAR_SEQ         281
FT                   /note="K -> KCWHQAYHKLGPQ (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:9242644"
FT                   /id="VSP_001549"
FT   VAR_SEQ         325..339
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9242644"
FT                   /id="VSP_001550"
SQ   SEQUENCE   759 AA;  83672 MW;  77231ED495840709 CRC64;
     MRTSPRRPLI LKRRRLPLPI QNAPSETSEE EAKRSPGQQE PTQAQASQDV AESSSCKFPA
     GIKIINHPTV PNTQVVAIPN NADIQSIITA LTAKGKESGS SGPNKFILIS SGGASSHPPD
     PQSQAQTSTD SKRTELITET LGPKPGAKGV PVPKPPGALP RQRQESCGGE AAGCTLDNSL
     TNIQWLGKMS SDGLGRCSIK QELEEKENCH LEQNRVKVEA PSRASVSWQD SVSERPPYSY
     MAMIQFAINS TERKRMTLKD IYTWIEDHFP YFKHIAKPGW KNSIRHNLSL HDMFVRETSA
     NGKVSFWTIH PSANRYLTLD QVFKPLEPGS PQSPEHLESQ QKRPNPELRR NVTIKTELPL
     GARRKMKPLL PRVSSYLVPI QFPVNQSLVL QPSVKVPLPL AASLMSSELA RHSKRVRIAP
     KVLLSNEGIA PLPATEPMKE EKPLLGEGLL PLLPIQSIKE EVIQPGEDIP HLERPIKVES
     PPLEEWPSPC ASVKEELSNS WEDSSCSPTP KPKKSYCGLK SPTRCVSEML VTKRREKREV
     SRSRRKQHLQ PPCLDEPELF FSEDSSTFRP AMEILAESSE PAPQLSCPQE EGGPFKTPIK
     ETLPVSSTPS KSVLSRDPES WRLTPPAKVG GLDFSPVRTP QGAFGPLPDS LGLMELNTTP
     LKSVPLFDSP RELLNSEAFD LASDPFSSSP PPHLEAKPGS PELQVPSLSA NRSLTEGLVL
     DTMNDSLSKI LLDISFPGLE EDPLGPDNIN WSQFIPELR
//
